UNSPSC 51152112: Hydroxyzine/oxyphencyclimine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA802. This VA Drug Class (GA802) classifies this compound as belonging to the group ANTIMUSCARINIC/ANTIPASMODIC COMBINATIONS.

UNSPSC 51152112 Hydroxyzine/oxyphencyclimine is a Commodity code that covers pharmaceutical products procured by state and local health authorities, typically through county health departments and state health and human services agencies. Based on recent solicitations, the code captures purchases of specific medications and pharmaceutical compounds for community health initiatives, emergency response programs, and state pharmacy benefit administration. The issuing bodies include county public health departments and state-level health and human services commissions, which may act as centralized procurement hubs for multi-jurisdictional pharmacy programs or direct-to-provider distribution networks.

Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued an RFI in April 2026 exploring direct-to-manufacturer prescription fulfillment capabilities and vendor experience with self-insured health plans and state pharmacy benefit programs. Activity is concentrated in Florida and Texas, with procurement structured around supply contracts that include delivery, insurance compliance, and in some cases FEMA funding and federal environmental regulation adherence. Vendors must typically meet E-Verify requirements, maintain workers' compensation and liability coverage, and comply with drug-free workplace certification standards.